Physician profile
Aniqa Alam
NPI 1740244607
$1,114.28
in general payments reported to CMS, 2019-2025
16 companies · $346 in 2025
The $346 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $72.16 · 2021: $15.71 · 2022: $13.06 · 2023: $119 · 2024: $549 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,013.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $265.74 | 2024-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $235.60 | 2020-2025 | Xifaxan |
| Intercept Pharmaceuticals, INC. | $133.97 | 2020-2024 | Ocaliva |
| Lilly USA, LLC | $109.98 | 2024-2025 | Omvoh |
| Qol Medical, LLC | $66.47 | 2024 | Sucraid |
| Abbvie INC. | $51.69 | 2020-2021 | |
| Janssen Biotech, INC. | $44.19 | 2023-2025 | Simponi Aria, Simponi, Stelara |
| Ardelyx, INC. | $42.05 | 2024 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $36.75 | 2024 | |
| Genzyme Corporation | $26.69 | 2024 | |
| Heron Therapeutics, INC. | $19.82 | 2023 | Zynrelef |
| Nevro Corp. | $19.28 | 2023 | Senza |
| Merck Sharp & Dohme LLC | $18.93 | 2024 | Dificid |
| Madrigal Pharmaceuticals | $16.00 | 2024 | Resmetirom |
| Regeneron Healthcare Solutions, INC. | $14.06 | 2025 | Dupixent |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aniqa Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.